Avanir Pharmaceuticals Inc. Cl A (AVNR) News Nov 2

Avanir Pharmaceuticals Inc. Cl A (AVNR) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on AVNR
6 stocks to watch 3:06 p.m. Nov. 5, 2014 - The Trading Deck
U.S. markets break out, confirm primary uptrend 11:12 a.m. Nov. 3, 2014 - Michael Ashbaugh
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
5 stocks to watch 1:37 p.m. Sept. 24, 2014 - The Trading Deck
4 stocks to watch 2:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 7:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 7:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 4:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 3:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 5:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 4:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 5:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 9:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 4:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 12:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 9:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 8:27 a.m. April 6, 2010 - Val Brickates Kennedy


Other News on AVNR
Biggest Movers in Healthcare Stocks Now – AVNR COV BMRN ALXN 1:00 p.m. Nov. 19, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – CLDX AVNR AUXL AZN 6:15 a.m. Nov. 19, 2014 - InvestorPlace.com
Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed - Analyst Blog 5:40 p.m. Nov. 10, 2014 - Zacks.com
Avanir Pharmaceuticals (AVNR) Stock Drops After FDA Provides New Drug Application Feedback 11:25 a.m. Nov. 7, 2014 - TheStreet.com
Will Avanir Pharmaceuticals (AVNR) Stock React Today to This Analyst Action? 8:52 a.m. Nov. 4, 2014 - TheStreet.com
Looking For My Next Triple In Biotech 1:26 p.m. Oct. 31, 2014 - Seeking Alpha
Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR) 10:19 a.m. Oct. 31, 2014 - TheStreet.com
Avanir Pharmaceuticals, Inc. (AVNR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 31, 2014 - Zacks.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock 4:19 p.m. Oct. 30, 2014 - TheStreet.com
5 Stocks That Will See Huge Buying Friday on Russell 2000 Rebalance 7:48 a.m. Oct. 30, 2014 - 247WallSt.com
Hottest Healthcare Stocks Now – APTO AVNR CNC XRAY 8:45 a.m. Oct. 29, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI AVNR MWIV ABC 8:00 a.m. Oct. 27, 2014 - InvestorPlace.com
Genervon ALS drug shows encouraging results 8:27 a.m. Oct. 20, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
Intra-Cellular Therapies Reveals Top-line Data on ITI-007 - Analyst Blog 5:50 p.m. Oct. 16, 2014 - Zacks.com
Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog 6:04 p.m. Oct. 15, 2014 - Zacks.com
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog 5:30 p.m. Oct. 14, 2014 - Zacks.com
Avanir presents AVP-923 Phase 2 data at neurology meeting 5:34 p.m. Oct. 13, 2014 - Seeking Alpha
Micro-Cap ETF And The Falling Greenback 4:28 p.m. Oct. 13, 2014 - Benzinga.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock 4:17 p.m. Oct. 13, 2014 - TheStreet.com

Press Releases on AVNR
Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine 8:30 a.m. Nov. 7, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache" 3:01 p.m. Oct. 30, 2014 - PR Newswire - PRF
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 7:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014 3:15 p.m. Oct. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease 7:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 8:15 a.m. Sept. 29, 2014 - PR Newswire - PRF
Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir 7:50 a.m. Sept. 29, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 9:00 p.m. Sept. 23, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3:45 p.m. Sept. 22, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 8:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 7:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 7:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 8:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 8:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 3:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 7:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 8:15 a.m. July 21, 2014 - PR Newswire - PRF